Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting
Overview
Affiliations
Background: There are currently two tests for diagnosing latent tuberculosis infection (LTBI); TST and IGRA. However, it is still unclear that which one of these tests performs better in high TB-burden settings.
Methods: 1511 household contacts of pulmonary TB patients were enrolled to compare the performance of TST and IGRA for LTBI. At baseline all participant underwent testing for IGRA [QuantiFERON-TB® Gold In-tube (QFT-GIT) assay] and TST [2 tuberculin unit (TU), purified protein derivative (PPD), RT23, Staten Serum Institute (SSI), Copenhagen, Denmark]. All the household contacts were followed-up for two years for incident TB cases.
Results: Active TB was diagnosed in 76 household contacts at an incidence rate of 2.14 per 1000 person-years. Both, TST [Hazard Ratio (HR): 1.14, 95% confidence interval (CI): 0.72-1.79, p = 0.57], as well as QFT-GIT assay (HR: 1.66, 95% CI: 0.97-2.84, p = 0.06) results at baseline were not significantly associated with subsequent development of active TB among household contacts of pulmonary TB patients.
Conclusion: Neither TST nor IGRA predicted subsequent development of active TB among household contacts of pulmonary TB patients during follow-up. However, keeping in view the cost, and other logistics, TST remains the most preferred method for LTBI diagnosis in resource-limited, high TB-burden settings.
Advances in the Diagnosis of Latent Tuberculosis Infection.
Zhang H, Guan W, Zhou J Infect Drug Resist. 2025; 18:483-493.
PMID: 39882252 PMC: 11776534. DOI: 10.2147/IDR.S504632.
Chauhan A, Parmar M, Dash G, Solanki H, Chauhan S, Sahoo K Indian J Community Med. 2024; 49(5):669-680.
PMID: 39421504 PMC: 11482387. DOI: 10.4103/ijcm.ijcm_36_24.
Alshowair A, Assiri A, Balfas A, Alkhattabi R, Eltegani T, Altowairib S Int J Gen Med. 2024; 17:4475-4483.
PMID: 39372131 PMC: 11456276. DOI: 10.2147/IJGM.S472710.
Meregildo-Rodriguez E, Ortiz-Pizarro M, Asmat-Rubio M, Rojas-Benites M, Vasquez-Tirado G Infez Med. 2024; 32(3):292-311.
PMID: 39282545 PMC: 11392545. DOI: 10.53854/liim-3203-4.
Chacko B, Chaudhry D, Peter J, Khilnani G, Saxena P, Sehgal I Indian J Crit Care Med. 2024; 28(Suppl 2):S67-S91.
PMID: 39234233 PMC: 11369919. DOI: 10.5005/jp-journals-10071-24783.